SK bioscience, a local vaccine developer and manufacturer, signed a contract manufacturing organization (CMO) agreement with global healthcare company MSD for the production of its next-generation Zaire Ebola vaccine, according to the company, Monday. MSD has been working with Hilleman Laboratories, an international nonprofit research organization, to develop a next-generation Zaire Ebola vaccine candidate.